Shared Decision Making to Address Racial Disparities in Oral Anticoagulation Use in Patients With Non-valvular Atrial Fibrillation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Duke University
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Proportion of patients willing to participate as measured by enrollment log
- Status
- Not yet recruiting
- Last Updated
- last month
Overview
Brief Summary
The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures.
The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Black and White adults greater than or equal to 18 years of age
- •Clinical diagnosis of NVAF
- •CHA2DS2-VASc score greater than or equal to 2
- •New patient visit for initiation of oral anticoagulation at primary care and cardiology clinics
Exclusion Criteria
- •Unable to speak English
- •Unable to provide informed consent
Outcomes
Primary Outcomes
Proportion of patients willing to participate as measured by enrollment log
Time Frame: End of Study, 12 months
Rate of completion of questionnaire measures as measured by Research Electronic Data Capture (REDCAP)
Time Frame: End of Study, 12 months
Measured by RedCap (all questionnaires will be distributed through RedCap)
Percent of patients who stated that the intervention was acceptable as measured by patient and provider interviews.
Time Frame: 1 week post clinic visit
Proportion of patients willing to consent as measured by enrollment log
Time Frame: End of Study, 12 months
Rate of Patient Decision Support tool delivery and data capture as measured by web based data capture
Time Frame: End of Study, 12 months
Secondary Outcomes
- Decision Quality measured by use of the decision conflict scale(Clinical Day, up to 1 day)
- Decision to initiate systemic oral anticoagulation measured and documented by physician of record during clinic visit.(Clinical Day, up to 1 day)